REQUEST A DEMO
Total
USD $0.00
Search more companies

Sino Biopharmaceutical Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sino Biopharmaceutical Limited Profile Updated: September 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Sino Biopharmaceutical Limited is an enterprise in Hong Kong SAR, China, with the main office in Hong Kong. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on February 02, 2000. The total number of employees is currently 25,806 (2023). In Q2C2024, the company reported a net sales revenue increase of 4.26%. Over the same period, its total assets grew by 1.62%. In 2024, Sino Biopharmaceutical Limited’s net profit margin increased by 11.25%.

Headquarters
Unit 09, 41St Floor, Office Tower, Convention Plaza, 1 Harbour Road
Hong Kong; Hong Kong;

Contact Details: Purchase the Sino Biopharmaceutical Limited report to view the information.

Website: http://www.sinobiopharm.com

Basic Information
Total Employees:
Purchase the Sino Biopharmaceutical Limited report to view the information.
Outstanding Shares:
Purchase the Sino Biopharmaceutical Limited report to view the information.
Registered Capital:
Purchase the Sino Biopharmaceutical Limited report to view the information.
Financial Auditors:
Purchase the Sino Biopharmaceutical Limited report to view the information.
Incorporation Date:
February 02, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
12.56%
Purchase this report to view the information.
12.11%
Purchase this report to view the information.
8.97%
Purchase this report to view the information.
7.76%
Subsidiaries
Champ Profit (China) Limited
100%
Champion First Investments Limited (United Kingdom)
100%
Chia Tai Healthcare (Holding) Limited
100%
Company Performance
Financial values in the chart are available after Sino Biopharmaceutical Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
4.26%
Total operating revenue
4.39%
Operating profit (EBIT)
11.28%
EBITDA
6.03%
Net Profit (Loss) for the Period
70.65%
Total assets
1.62%
Total equity
15.53%
Operating Profit Margin (ROS)
1.42%
Net Profit Margin
11.25%
Return on Equity (ROE)
3.54%
Debt to Equity Ratio
-8.72%
Quick Ratio
0.14%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?